IL102815A - Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus - Google Patents

Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus

Info

Publication number
IL102815A
IL102815A IL102815A IL10281592A IL102815A IL 102815 A IL102815 A IL 102815A IL 102815 A IL102815 A IL 102815A IL 10281592 A IL10281592 A IL 10281592A IL 102815 A IL102815 A IL 102815A
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical compositions
immunodeficiency virus
human immunodeficiency
infection caused
Prior art date
Application number
IL102815A
Other versions
IL102815A0 (en
Original Assignee
Sequus Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequus Pharmaceuticals filed Critical Sequus Pharmaceuticals
Publication of IL102815A0 publication Critical patent/IL102815A0/en
Publication of IL102815A publication Critical patent/IL102815A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IL102815A 1991-08-14 1992-08-14 Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus IL102815A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74491591A 1991-08-14 1991-08-14

Publications (2)

Publication Number Publication Date
IL102815A0 IL102815A0 (en) 1993-01-31
IL102815A true IL102815A (en) 1997-09-30

Family

ID=24994455

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102815A IL102815A (en) 1991-08-14 1992-08-14 Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus

Country Status (5)

Country Link
EP (1) EP0599977A1 (en)
AU (1) AU664857B2 (en)
CA (1) CA2113272A1 (en)
IL (1) IL102815A (en)
WO (1) WO1993003737A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683723B1 (en) * 1991-11-14 1995-05-19 Mayoly Spindler Laboratoires NEW ANTIVIRAL DRUGS ACTIVE ON THE HIV VIRUS.
GB2290707A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of Amphotericin B
GB2290708A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of polyene macrolides
CA2432319A1 (en) 2000-12-21 2002-07-18 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
WO2022219386A1 (en) * 2021-04-16 2022-10-20 Pannonpharma Gyógyszergyártó Kft. Treatment for viral infection with polyene macrolide antibiotic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822777A (en) * 1987-02-27 1989-04-18 Liposome Technology, Inc. Amphotericin B/cholesterol sulfate composition
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
US5032404A (en) * 1989-02-23 1991-07-16 Board Of Regents, The University Of Texas System Lipsome-incorporation of polyenes

Also Published As

Publication number Publication date
CA2113272A1 (en) 1993-03-04
IL102815A0 (en) 1993-01-31
AU2473092A (en) 1993-03-16
EP0599977A1 (en) 1994-06-08
AU664857B2 (en) 1995-12-07
WO1993003737A1 (en) 1993-03-04

Similar Documents

Publication Publication Date Title
MA22842A1 (en) PROCESS FOR THE PREPARATION OF VACCINE COMPOSITIONS.
ITMI931522A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION (HBV)
LTIP335A (en) Vaccine for human immunodeficiency virus
AU1463992A (en) Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
EP0522081A4 (en) Inhibition of disease associated with immunodeficiency virus infection
MX9200146A (en) SWALLOWABLE PHARMACEUTICAL COMPOSITIONS
ITMI910456A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CATARACT
IL105169A0 (en) Compositions for the treatment of infection and disease caused by hepatitis b virus(hbv)
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL100243A0 (en) Pharmaceutical compositions for the treatment of erythrocytic malaria infections
EP0491873A4 (en) Therapeutic compositions; methods for treatment of hiv infections
EP0655919A4 (en) Treatment of human viral infections.
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
EP0248361A3 (en) Pharmaceutical preparation for the treatment of bacterial infections
HU9503351D0 (en) Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
IL96667A0 (en) Pharmaceutical compositions containing fibroblast growth factors for the prevention and treatment of viral infections
IL84550A (en) Pharmaceutical compositions for treatment of viral infections containing 3( -fluoro-3(-deoxy-thymidine
LTIP472A (en) Composition for the treatment of infection and disease caused by hepatit b virus
IL106939A0 (en) Pharmaceutical compositions for treating viral infections
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
IL89658A0 (en) Aqueous pharmaceutical composition for impeding the deterioration of patients carrying the aids virus

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees